Cancer testis antigen expression in testicular germ cell tumorigenesis.
Cancer testis antigens are encoded by germ line-associated genes that are present in normal germ cells of testis and ovary but not in differentiated tissues. Their expression in various human cancer types has been interpreted as 're-expression' or as intratumoral progenitor cell signature. Cancer testis antigen expression patterns have not yet been studied in germ cell tumorigenesis with specific emphasis on intratubular germ cell neoplasia unclassified as a precursor lesion for testicular germ cell tumors. Immunohistochemistry was used to study MAGEA3, MAGEA4, MAGEC1, GAGE1 and CTAG1B expression in 325 primary testicular germ cell tumors, including 94 mixed germ cell tumors. Seminomatous and non-seminomatous components were separately arranged and evaluated on tissue microarrays. Spermatogonia in the normal testis were positive, whereas intratubular germ cell neoplasia unclassified was negative for all five CT antigens. Cancer testis antigen expression was only found in 3% (CTAG1B), 10% (GAGE1, MAGEA4), 33% (MAGEA3) and 40% (MAGEC1) of classic seminoma but not in non-seminomatous testicular germ cell tumors. In contrast, all spermatocytic seminomas were positive for cancer testis antigens. These data are consistent with a different cell origin in spermatocytic seminoma compared with classic seminoma and support a progression model with loss of cancer testis antigens in early tumorigenesis of testicular germ cell tumors and later re-expression in a subset of seminomas.
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
Peter K
PK
Bode
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
Andrea
A
Thielken
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
Simone
S
Brandt
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
André
A
Barghorn
Institute of Pathology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Bernd
B
Lohe
Clinic of Oncology, University Hospital Zurich, Zurich, Switzerland.
Alexander
A
Knuth
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
Holger
H
Moch
D000951:Antigens, Neoplasm / Q000032:analysis* / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000032:analysis; D063646:Carcinogenesis / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008565:Membrane Proteins / Q000096:biosynthesis; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009373:Neoplasms, Germ Cell and Embryonal / Q000378:metabolism* / Q000473:pathology; D013736:Testicular Neoplasms / Q000378:metabolism* / Q000473:pathology; D046888:Tissue Array Analysis
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C104948:CTAG1B protein, human; C095365:GAGE1 protein, human; C072013:MAGEA3 protein, human; C095204:MAGEA4 protein, human; C110905:MAGEC1 protein, human; D008565:Membrane Proteins; D009363:Neoplasm Proteins